secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2024-03-29T23:59:59+00:00
Accession:  0001213900-24-027972
Event type: regulatory
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma regains NYSE American compliance after reverse stock split
-----------------------------------------------------------------------

- Received NYSE American notice on March 27, 2024 confirming compliance with continued listing standards.
- Resolved low selling price deficiency (Section 1003(f)(v)) via 1-for-5 reverse stock split on March 6, 2024.
- ".BC" indicator to be removed; company removed from noncompliant issuers list.
- NYSE American cautioned that no cure period exists if stock again trades at abnormally low levels.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390024027972/0001213900-24-027972-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390024027972/ea0202916-8k_chinapharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-027972

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer